ATE349417T1 - 5-aminolaevulinsäure-ester als mittel zur photosensibilisierung in der chemotherapie - Google Patents
5-aminolaevulinsäure-ester als mittel zur photosensibilisierung in der chemotherapieInfo
- Publication number
- ATE349417T1 ATE349417T1 AT01984415T AT01984415T ATE349417T1 AT E349417 T1 ATE349417 T1 AT E349417T1 AT 01984415 T AT01984415 T AT 01984415T AT 01984415 T AT01984415 T AT 01984415T AT E349417 T1 ATE349417 T1 AT E349417T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- alkyl group
- aminolaevulic
- chemotherapy
- acid ester
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 238000002512 chemotherapy Methods 0.000 title 1
- 239000003504 photosensitizing agent Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 3
- 238000003745 diagnosis Methods 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 abstract 1
- 230000005856 abnormality Effects 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 abstract 1
- 125000005907 alkyl ester group Chemical group 0.000 abstract 1
- 229960002749 aminolevulinic acid Drugs 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000004043 oxo group Chemical group O=* 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0018528.0A GB0018528D0 (en) | 2000-07-27 | 2000-07-27 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE349417T1 true ATE349417T1 (de) | 2007-01-15 |
Family
ID=9896500
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01984415T ATE349417T1 (de) | 2000-07-27 | 2001-07-25 | 5-aminolaevulinsäure-ester als mittel zur photosensibilisierung in der chemotherapie |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US7217736B2 (enExample) |
| EP (1) | EP1313695B1 (enExample) |
| JP (1) | JP5010088B2 (enExample) |
| KR (1) | KR20030028554A (enExample) |
| CN (1) | CN1318388C (enExample) |
| AT (1) | ATE349417T1 (enExample) |
| AU (2) | AU2749502A (enExample) |
| CA (1) | CA2416307C (enExample) |
| CZ (1) | CZ2003260A3 (enExample) |
| DE (1) | DE60125555T2 (enExample) |
| DK (1) | DK1313695T3 (enExample) |
| ES (1) | ES2276844T3 (enExample) |
| GB (1) | GB0018528D0 (enExample) |
| HU (1) | HUP0301427A2 (enExample) |
| NO (1) | NO20030398L (enExample) |
| NZ (1) | NZ523927A (enExample) |
| PT (1) | PT1313695E (enExample) |
| RU (1) | RU2246483C2 (enExample) |
| WO (1) | WO2002010120A1 (enExample) |
Families Citing this family (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6492420B2 (en) * | 1995-03-10 | 2002-12-10 | Photocure As | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| US20090297602A1 (en) * | 1998-11-02 | 2009-12-03 | Devane John G | Modified Release Loxoprofen Compositions |
| IL142896A0 (en) * | 1998-11-02 | 2002-04-21 | Elan Corp Plc | Multiparticulate modified release composition |
| US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US7232924B2 (en) | 2001-06-11 | 2007-06-19 | Xenoport, Inc. | Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| AU2002310409C1 (en) | 2001-06-11 | 2008-04-17 | Xenoport, Inc. | Orally administered dosage forms of GABA analog prodrugs having reduced toxicity |
| US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| GB0118251D0 (en) * | 2001-07-26 | 2001-09-19 | Photocure Asa | Method |
| CA2500908A1 (en) * | 2002-10-04 | 2004-04-22 | Elan Pharma International Limited | Gamma irradiation of solid nanoparticulate active agents |
| DE10312659A1 (de) * | 2003-03-21 | 2004-10-07 | Universität Regensburg | 5-Aminolävulinsäurederivate und ihre Verwendung |
| US7842232B2 (en) * | 2003-05-22 | 2010-11-30 | Elan Pharma International, Ltd. | Sterilization of dispersions of nanoparticulate active agents with gamma radiation |
| CA2437638A1 (en) | 2003-08-20 | 2005-02-20 | John Robert North | Photodynamic therapy |
| CA2457214A1 (en) | 2004-02-06 | 2005-08-06 | Qlt Inc. | Photodynamic therapy for the treatment of acne |
| GB0406917D0 (en) | 2004-03-26 | 2004-04-28 | Photocure Asa | Compounds |
| JP2005350418A (ja) * | 2004-06-11 | 2005-12-22 | Shibuya Kogyo Co Ltd | 標的細胞の死滅方法と標的細胞を死滅させるための薬剤及び該薬剤の製造装置 |
| EP2727589B1 (en) | 2004-09-02 | 2018-11-28 | neo ALA Co., Ltd. | Constitutional function-improving agents |
| EP1811986B1 (en) | 2004-11-04 | 2014-03-26 | XenoPort, Inc. | Gabapentin prodrug sustained release oral dosage forms |
| GB0424833D0 (en) | 2004-11-10 | 2004-12-15 | Photocure Asa | Method |
| EP1855651A4 (en) * | 2005-03-03 | 2011-06-15 | Elan Pharma Int Ltd | NANOPARTICLE COMPOSITIONS OF HETEROCYCLIC AMID DERIVATIVES |
| JP4934292B2 (ja) * | 2005-07-05 | 2012-05-16 | コスモ石油株式会社 | ５−アミノレブリン酸エステルリン酸類塩、その製造方法及びその用途 |
| JP4934293B2 (ja) * | 2005-07-05 | 2012-05-16 | コスモ石油株式会社 | 植物活力剤組成物 |
| GB0609809D0 (en) * | 2006-05-17 | 2006-06-28 | Photocure Asa | Product |
| JP2009543803A (ja) * | 2006-07-12 | 2009-12-10 | エラン・ファルマ・インターナショナル・リミテッド | モダフィニルのナノ粒子製剤 |
| JP5404995B2 (ja) | 2006-08-10 | 2014-02-05 | コスモ石油株式会社 | 植物のポリフェノール増量剤 |
| GB0700580D0 (en) | 2007-01-11 | 2007-02-21 | Photocure Asa | Use |
| US20090036952A1 (en) | 2007-07-30 | 2009-02-05 | National Yang-Ming University | Induction driven light module and use thereof |
| GB0718957D0 (en) * | 2007-09-28 | 2007-11-07 | Ge Healthcare Ltd | Optical imaging agents |
| KR100883560B1 (ko) * | 2007-08-23 | 2009-02-17 | (주) 위디어 | 신규한 5-아미노레불린 산 유도체 및 이의 제조방법 |
| GB0724279D0 (en) * | 2007-12-12 | 2008-01-23 | Photocure Asa | Use |
| AU2008337067A1 (en) * | 2007-12-14 | 2009-06-25 | Photoderma Sa | Novel compounds useful in therapeutic and cosmetic methods |
| GB0804190D0 (en) * | 2008-03-06 | 2008-04-16 | Ge Healthcare Ltd | Ester imaging agents |
| US8563605B2 (en) | 2008-05-14 | 2013-10-22 | Sbi Pharmaceuticals Co., Ltd. | Therapeutic agent for male sterility |
| CA2735426A1 (en) | 2008-09-01 | 2010-03-04 | Swedish Pharma Ab | New 5-aminolevulinic acid prodrugs for use in photodynamic therapy and photodynamic diagnosis |
| GB0823472D0 (en) | 2008-12-23 | 2009-01-28 | Photocure Asa | Product |
| GB0900461D0 (en) | 2009-01-12 | 2009-02-11 | Photocure Asa | Photodynamic therapy device |
| AU2010257752B2 (en) * | 2009-06-11 | 2015-04-09 | Photocure Asa | Solid compositions comprising 5-aminolevulinic acid |
| WO2010142457A1 (en) * | 2009-06-11 | 2010-12-16 | Photocure Asa | Semi-solid compositions and pharmaceutical products |
| JP2013521251A (ja) | 2010-03-01 | 2013-06-10 | フォトキュア エイエスエイ | 美容組成物 |
| EP2394642A1 (en) | 2010-06-10 | 2011-12-14 | Universite De Geneve | 5-ALA ester formulations and use thereof |
| US20130211215A1 (en) | 2010-06-23 | 2013-08-15 | Photocure Asa | Hyperosmotic preparations comprising 5-aminolevulinic acid or derivative as photosensitizing agent |
| CA2804337A1 (en) | 2010-07-09 | 2012-01-12 | Photocure Asa | Dry compositions and devices containing such dry compositions for use in photodynamic therapy or photodynamic diagnosis |
| JP6323978B2 (ja) | 2010-12-24 | 2018-05-16 | アークレイ株式会社 | 癌細胞の検出方法 |
| CA2824768A1 (en) | 2011-01-13 | 2012-07-19 | Qlt Inc. | Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof |
| US20140316534A1 (en) | 2011-10-14 | 2014-10-23 | Photocure Asa | Stent |
| US20140276107A1 (en) | 2011-10-14 | 2014-09-18 | Photocure Asa | Photodynamic diagnosis |
| BR112014014847B1 (pt) | 2011-12-19 | 2022-08-16 | Photocure Asa | Aparelho de aplicação de luz portátil, autônomo, para tratamento fotodinâmico da vulva, e kit |
| WO2013092936A2 (en) | 2011-12-20 | 2013-06-27 | Galderma Research & Development | Use of 5-aminolevulinic acid and esters, in combination with a vitamin d derivative or analog in photochemotherapy, and their uses in treating acne |
| WO2014011875A1 (en) | 2012-07-11 | 2014-01-16 | Dermira, Inc. | Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof |
| RU2635563C2 (ru) | 2012-08-03 | 2017-11-14 | ФотоКьюэр АСА | Соединения |
| GB201215675D0 (en) | 2012-09-03 | 2012-10-17 | Univ Exeter | Compound |
| GB201221123D0 (en) | 2012-11-23 | 2013-01-09 | Photocure As | Device for photodynamic treatment |
| GB201306369D0 (en) | 2013-04-09 | 2013-05-22 | Photocure As | Irradiation device |
| CN105899201A (zh) | 2013-12-20 | 2016-08-24 | 盖尔德马研究及发展公司 | 光损伤的皮肤的脉冲光动力治疗 |
| EP3102195B1 (en) | 2014-02-03 | 2021-10-06 | Quadriga Biosciences, Inc. | Beta-substituted beta-amino acids and analogs as chemotherapeutic agents |
| EP3095464A1 (en) | 2015-05-19 | 2016-11-23 | Universite De Geneve | 5-ala derivatives and use thereof |
| AR105592A1 (es) | 2015-08-03 | 2017-10-18 | Quadriga Biosciences Inc | b-AMINOÁCIDOS b-SUSTITUIDOS Y ANÁLOGOS COMO AGENTES QUIMIOTERAPÉUTICOS Y USOS DE LOS MISMOS |
| GB201522309D0 (en) * | 2015-12-17 | 2016-02-03 | Photocure Asa | Use |
| GB201522398D0 (en) | 2015-12-18 | 2016-02-03 | Photocure As | Device for photodynamic therapy |
| CN112010772A (zh) | 2016-01-26 | 2020-12-01 | 赵鸣 | 5-氨基酮戊酸及其衍生物的盐化合物和应用 |
| ES2859777T3 (es) | 2017-02-06 | 2021-10-04 | 3Skin As | Composición de filtro solar |
| DK3641882T3 (da) * | 2017-06-21 | 2023-12-18 | Photocure Asa | Fremgangsmåde til fremstilling af en flydende farmaceutisk sammensætning og indretning til anvendelse i en sådan fremgangsmåde |
| EP3868372A1 (en) | 2020-02-19 | 2021-08-25 | JLP Health GmbH | A pharmaceutical combination of an artemisinin compound and a heme synthesis modulator for treating cancer |
| CN111635464B (zh) * | 2020-05-12 | 2022-03-25 | 上海易全化学有限公司 | 一种5-氨基酮戊酸葡聚糖酯的制备方法 |
| WO2026084589A1 (en) | 2024-10-14 | 2026-04-23 | Universiteit Van Amsterdam | G4-destabiling small molecules for the treatment of x-linked dystonia-parkinsonism. |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4087532A (en) * | 1974-03-09 | 1978-05-02 | Boehringer Ingelheim Gmbh | Analgesically useful 2-tetrahydrofurfuryl-5-lower alkyl-2-oxy-6,7-benzomorphans and salts thereof |
| DE2411382C3 (de) | 1974-03-09 | 1979-09-06 | C.H. Boehringer Sohn, 6507 Ingelheim | 2-Tetrahydrofurfuryl-6,7-benzomorphane, Verfahren zur Herstellung und deren Verwendung |
| GB2058077B (en) | 1979-06-08 | 1983-03-09 | Szelke M | Enkephalin analogues |
| CA1236029A (en) * | 1984-05-14 | 1988-05-03 | Edmund Sandborn | Pharmaceutical solutions comprising dimethyl sulfoxide |
| SE460947B (sv) | 1986-08-26 | 1989-12-11 | Lejus Medical Ab | En multiple-unit-dos komposition av l-dopa |
| JPS6452778A (en) * | 1987-05-30 | 1989-02-28 | Tokuyama Soda Kk | Fulgide compound and production thereof |
| JPH0745502B2 (ja) * | 1987-11-10 | 1995-05-17 | 株式会社トクヤマ | 新規化合物及びそれを含む組成物 |
| US5422093A (en) * | 1989-07-28 | 1995-06-06 | Queen's University | Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof |
| US5079262A (en) * | 1989-07-28 | 1992-01-07 | Queen's University At Kingston | Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid |
| US5234940A (en) * | 1989-07-28 | 1993-08-10 | Queen's University | Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof |
| US5955490A (en) * | 1989-07-28 | 1999-09-21 | Queen's University At Kingston | Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins |
| JP2767318B2 (ja) | 1990-04-11 | 1998-06-18 | 株式会社コスモ総合研究所 | ５―アミノレブリン酸アルキルエステル又はその塩及びその製造方法並びにこれを有効成分とする除草剤 |
| EP0553116A1 (en) | 1990-10-05 | 1993-08-04 | Queen's University At Kingston | Porphyrin derivatives |
| US5219878A (en) * | 1990-10-05 | 1993-06-15 | Queen's University | Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents |
| JP2747644B2 (ja) * | 1993-08-19 | 1998-05-06 | 株式会社コスモ総合研究所 | 植物成長調節剤 |
| GB9318841D0 (en) | 1993-09-10 | 1993-10-27 | Res Foundation Of The Norwegia | Composition |
| JP2896963B2 (ja) * | 1994-11-28 | 1999-05-31 | 株式会社コスモ総合研究所 | 植物の耐塩性向上剤 |
| DE122006000051I1 (de) * | 1995-03-10 | 2007-01-04 | Photocure Asa | Ester der 5-Aminolevulins{ure als Mittel zur Photosensibillisierung in der Chemotherapie |
| US7530461B2 (en) | 1995-03-10 | 2009-05-12 | Photocure Asa | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| US6492420B2 (en) * | 1995-03-10 | 2002-12-10 | Photocure As | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| US6992107B1 (en) * | 1995-03-10 | 2006-01-31 | Photocure Asa | Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy |
| GB9504948D0 (en) * | 1995-03-10 | 1995-04-26 | Norwegian Radium Hospital Rese | Compounds |
| GB9700396D0 (en) * | 1997-01-10 | 1997-02-26 | Photocure As | Photochemotherapeutic compositions |
| FR2777782B1 (fr) | 1998-04-22 | 2001-05-18 | Alexandre Marti | Solution pour la preparation d'une substance pharmaceutique pour le diagnostic et/ou le traitement de lesions tissulaires |
| GB0018527D0 (en) * | 2000-07-27 | 2000-09-13 | Photocure Asa | Composition |
| GB0118251D0 (en) | 2001-07-26 | 2001-09-19 | Photocure Asa | Method |
| GB0128052D0 (en) | 2001-11-22 | 2002-01-16 | Drug Discovery Lab As | Compounds |
-
2000
- 2000-07-27 GB GBGB0018528.0A patent/GB0018528D0/en not_active Ceased
-
2001
- 2001-07-25 PT PT01984415T patent/PT1313695E/pt unknown
- 2001-07-25 ES ES01984415T patent/ES2276844T3/es not_active Expired - Lifetime
- 2001-07-25 DE DE60125555T patent/DE60125555T2/de not_active Expired - Lifetime
- 2001-07-25 AU AU2749502A patent/AU2749502A/xx active Pending
- 2001-07-25 NZ NZ523927A patent/NZ523927A/en not_active IP Right Cessation
- 2001-07-25 RU RU2003105460/04A patent/RU2246483C2/ru not_active IP Right Cessation
- 2001-07-25 DK DK01984415T patent/DK1313695T3/da active
- 2001-07-25 WO PCT/GB2001/003336 patent/WO2002010120A1/en not_active Ceased
- 2001-07-25 EP EP01984415A patent/EP1313695B1/en not_active Expired - Lifetime
- 2001-07-25 KR KR10-2003-7001213A patent/KR20030028554A/ko not_active Withdrawn
- 2001-07-25 CZ CZ2003260A patent/CZ2003260A3/cs unknown
- 2001-07-25 CA CA2416307A patent/CA2416307C/en not_active Expired - Fee Related
- 2001-07-25 JP JP2002516252A patent/JP5010088B2/ja not_active Expired - Fee Related
- 2001-07-25 CN CNB018146953A patent/CN1318388C/zh not_active Expired - Fee Related
- 2001-07-25 AU AU2002227495A patent/AU2002227495B2/en not_active Ceased
- 2001-07-25 HU HU0301427A patent/HUP0301427A2/hu unknown
- 2001-07-25 US US10/343,209 patent/US7217736B2/en not_active Expired - Fee Related
- 2001-07-25 AT AT01984415T patent/ATE349417T1/de active
-
2003
- 2003-01-24 NO NO20030398A patent/NO20030398L/no not_active Application Discontinuation
-
2007
- 2007-04-13 US US11/786,878 patent/US7563819B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1313695B1 (en) | 2006-12-27 |
| US7217736B2 (en) | 2007-05-15 |
| NO20030398D0 (no) | 2003-01-24 |
| DK1313695T3 (da) | 2007-04-30 |
| US7563819B1 (en) | 2009-07-21 |
| EP1313695A1 (en) | 2003-05-28 |
| US20040106679A1 (en) | 2004-06-03 |
| PT1313695E (pt) | 2007-01-31 |
| CZ2003260A3 (cs) | 2003-06-18 |
| CN1318388C (zh) | 2007-05-30 |
| NO20030398L (no) | 2003-03-12 |
| KR20030028554A (ko) | 2003-04-08 |
| CN1460099A (zh) | 2003-12-03 |
| HUP0301427A2 (hu) | 2003-09-29 |
| AU2002227495B2 (en) | 2006-01-05 |
| AU2749502A (en) | 2002-02-13 |
| ES2276844T3 (es) | 2007-07-01 |
| CA2416307C (en) | 2013-01-22 |
| CA2416307A1 (en) | 2002-02-07 |
| DE60125555D1 (de) | 2007-02-08 |
| GB0018528D0 (en) | 2000-09-13 |
| NZ523927A (en) | 2004-07-30 |
| JP2004505105A (ja) | 2004-02-19 |
| WO2002010120A1 (en) | 2002-02-07 |
| RU2246483C2 (ru) | 2005-02-20 |
| DE60125555T2 (de) | 2007-10-11 |
| JP5010088B2 (ja) | 2012-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60125555D1 (de) | 5-aminolaevulinsäure-ester als mittel zur photosensibilisierung in der chemotherapie | |
| NO20071042L (no) | 5-substituerte 2-fenylaminobenzamider som MEK-inhibitorer | |
| CA2215069A1 (en) | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy | |
| EP1403255A4 (en) | RHO KINASE INHIBITORS | |
| BRPI0818193B8 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| AR063331A1 (es) | Derivados de biaril eter urea y composiciones farmaceuticas | |
| JO2643B1 (en) | Derivatives of 2-aryl-6-phenylimidazole [a-1,2] pyridine, their preparation and therapeutic use | |
| ATE484504T1 (de) | Imidazo ä1,2-aüpyridin-2-carboxamid-derivate, herstellungsverfahren und ihre verwendung für therapeutika | |
| EA201170094A1 (ru) | Производные замещенного пиримидо[2,1-а]изохинолин-4-она | |
| AR072227A1 (es) | Derivados de triazinona sustituidos | |
| NO20063821L (no) | Kinolinderivater for anvendelse som mykobakterielle inhibitorer | |
| MA30821B1 (fr) | Derives de pyrazoline utiles comme antagonistes des recepteurs de mineralocorticoïdes | |
| HRP20130327T1 (hr) | Novi derivati dihidroindolona, postupak za njihovu pripravu i farmaceutski spojevi koji ih sadržavaju | |
| ES2675169T3 (es) | Procedimientos de tratamiento de las afecciones relacionadas con el cabello | |
| ATE548019T1 (de) | Hautaufhellende mittel, zusammensetzungen und verfahren | |
| MA29943B1 (fr) | Derives de pyrazolo[4,3-d] pyrimidine-5-yle utilises comme inhibiteurs de pde5 | |
| WO2002078615A3 (en) | Antioxidant nitroxides and nitrones as therapeutic agents | |
| ZA200704913B (en) | 3-[2-(3-acylamino-2-oxo-2H-pyridin-1-YL)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors | |
| DE602006008962D1 (de) | Verfahren zur herstellung von valsartan | |
| WO2001070693A3 (en) | Difluorobutyric acid derivatives and their use as metalloprotease inhibitors | |
| TNSN08287A1 (en) | 3,5-substituted piperidine compounds as renin inhibitors | |
| AR038967A1 (es) | Derivados de 2,3 - diaril - pirazolidinas como inhibidores de enzimas que degradan la neurotensina | |
| WO2008093740A1 (ja) | ホップのアルファ酸又はホップオイル含量向上剤 | |
| AR078819A1 (es) | Derivados de aminotiazol inhibidores de calicreina tisular humana klk1), composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades inflamatorias respiratorias, tales como asma, entre otras. | |
| HUE029645T2 (en) | New 1,3-benzoxazol-2 (3H) -one derivatives and their use as drugs and cosmetics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1313695 Country of ref document: EP |